Comparison 10. Subgroup analysis for ESKD: steroid versus no steroid regimen.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 ESKD	8	741	Risk Ratio (IV, Random, 95% CI)	0.39 [0.23, 0.65]
1.1 Baseline ACEi/ARB	4	484	Risk Ratio (IV, Random, 95% CI)	0.35 [0.17, 0.75]
1.2 No baseline ACEi/ARB	4	257	Risk Ratio (IV, Random, 95% CI)	0.42 [0.20, 0.87]